ReviewFrontiers in immunology2022

Regulating Histone Deacetylase Signaling Pathways of Myeloid-Derived Suppressor Cells Enhanced T Cell-Based Immunotherapy.

Adeleye O Adeshakin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.